
Samantha Sault
Writer and Editor at Freelance
Chief Editorial Officer & Shareholder, @qorvis - Founder, The Samantha Sault Agency - Author @MoonGuides #WashingtonDC at @HachetteUS
Articles
-
1 week ago |
bio.news | Samantha Sault
On Day 1 of the 2025 Biotechnology Innovation Organization (BIO) International Convention, a clear challenge was issued to the biotech industry: redefine how we understand, research, and invest in women’s health. Only 5% of conditions affecting women are exclusively gynecological or reproductive in nature.
-
Nov 21, 2024 |
bio.news | Samantha Sault |Camila Zavala
On November 19, the Biotechnology Innovation Organization (BIO) Clinical Trial Diversity Summit brought together a dynamic mix of researchers, industry leaders, policymakers, and community advocates at Howard University in Washington, D.C. Organized in collaboration with Howard University and the Diversity Convergence Project, the summit addressed one of the most pressing issues in clinical research: the lack of diversity and inclusion in clinical trials.
-
Mar 29, 2024 |
bio.news | David Thomas |Samantha Sault |CFA David Thomas
A year ago, the sentiment for the industry was extremely low. In 2023, the biotech stock indices were sliding to potential new lows, levels not seen since 2017. Everything from venture capital to licensing was trending down significantly, and we were coming off the heels of the newly passed Inflation Reduction Act (IRA). It was hard to find positive signals to present at events such as BIO-Europe. But things have changed heading into 2024.
-
Mar 5, 2024 |
bio.news | Samantha Sault
The Biotechnology Innovation Organization (BIO) 2024 CEO and Investor Conference (a.k.a. #BIOCEO24) took place February 26-27 in New York. The annual event brought together more than 1,000 attendees for a week of insightful panel discussions, networking, and BIO One-on-One Partnering™ to drive tomorrow’s biotech innovations.
-
Mar 1, 2024 |
bio.news | Samantha Sault
On Monday, March 4, the White House will host a “listening session” on the impact of Pharmacy Benefit Managers (PBMs). This is a welcome effort to gather more information and perspective on what patients and families are facing, and there’s no doubt that the stories that will be shared will be illuminating. In the spirit of “listening,” here are five realities that we hope come through loud and clear on Monday:1. Patients must come first.
Try JournoFinder For Free
Search and contact over 1M+ journalist profiles, browse 100M+ articles, and unlock powerful PR tools.
Start Your 7-Day Free Trial →X (formerly Twitter)
- Followers
- 1K
- Tweets
- 6K
- DMs Open
- No